FR18C1029I2 - Dihydroquinazolines substituees a proprietes antivirales - Google Patents

Dihydroquinazolines substituees a proprietes antivirales

Info

Publication number: FR18C1029I2
Authority: FR; France
Prior art keywords: antiviral properties; dihydroquinazolines; substituted; substituted dihydroquinazolines; antiviral
Prior art date: 2003-05-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR18C1029C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Aicuris Anti Infectives Cures GmbH

Original Assignee

Aicuris Anti Infectives Cures GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-02

Filing date

2018-07-06

Publication date

2020-07-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33305099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR18C1029(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2018-07-06 Application filed by Aicuris Anti Infectives Cures GmbH filed Critical Aicuris Anti Infectives Cures GmbH

2018-08-17 Publication of FR18C1029I1 publication Critical patent/FR18C1029I1/fr

2020-07-17 Application granted granted Critical

2020-07-17 Publication of FR18C1029I2 publication Critical patent/FR18C1029I2/fr

Status Active legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

FR18C1029C 2003-05-02 2018-07-06 Dihydroquinazolines substituees a proprietes antivirales Active FR18C1029I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10319612A DE10319612A1 (de)	2003-05-02	2003-05-02	Substituierte Dihydrochinazoline
PCT/EP2004/004103 WO2004096778A1 (fr)	2003-05-02	2004-04-17	Dihydroquinazolines substituees a proprietes antivirales

Publications (2)

Publication Number	Publication Date
FR18C1029I1 FR18C1029I1 (fr)	2018-08-17
FR18C1029I2 true FR18C1029I2 (fr)	2020-07-17

Family

ID=33305099

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR18C1029C Active FR18C1029I2 (fr)	2003-05-02	2018-07-06	Dihydroquinazolines substituees a proprietes antivirales

Country Status (38)

Country	Link
US (4)	US7196086B2 (fr)
EP (1)	EP1622880B3 (fr)
JP (1)	JP4733631B2 (fr)
KR (1)	KR100927063B1 (fr)
CN (1)	CN100393706C (fr)
AR (1)	AR044078A1 (fr)
AT (1)	ATE355280T1 (fr)
AU (1)	AU2004233978B2 (fr)
BR (1)	BRPI0410029B8 (fr)
CA (1)	CA2524069C (fr)
CL (1)	CL2004000930A1 (fr)
CO (1)	CO5700764A2 (fr)
CY (2)	CY1106476T1 (fr)
DE (2)	DE10319612A1 (fr)
DK (1)	DK1622880T6 (fr)
EC (1)	ECSP056138A (fr)
EG (1)	EG25273A (fr)
ES (1)	ES2284007T7 (fr)
FR (1)	FR18C1029I2 (fr)
HN (1)	HN2004000146A (fr)
HU (2)	HUS1800018I1 (fr)
IL (1)	IL171513A (fr)
MA (1)	MA27794A1 (fr)
MX (1)	MXPA05011707A (fr)
MY (1)	MY144616A (fr)
NL (1)	NL300933I2 (fr)
NO (2)	NO333265B3 (fr)
NZ (1)	NZ543317A (fr)
PE (1)	PE20050145A1 (fr)
PL (1)	PL1622880T6 (fr)
PT (1)	PT1622880E (fr)
RU (1)	RU2360912C2 (fr)
SI (1)	SI1622880T1 (fr)
TW (1)	TWI335912B (fr)
UA (1)	UA82519C2 (fr)
UY (1)	UY28294A1 (fr)
WO (1)	WO2004096778A1 (fr)
ZA (1)	ZA200508710B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10319612A1 (de)	2003-05-02	2004-11-18	Bayer Healthcare Ag	Substituierte Dihydrochinazoline
DE10305785A1 (de) *	2003-02-12	2004-08-26	Bayer Healthcare Ag	Dihydrochinazoline
DE10320780A1 (de)	2003-05-09	2005-01-20	Bayer Healthcare Ag	Heterocyclyl-substituierte Dihydrochinazoline
DE10352499A1 (de)	2003-11-11	2005-06-09	Bayer Healthcare Ag	Substituierte Dihydrochinazoline II
DE102004022672A1 (de) *	2004-05-07	2005-11-24	Bayer Healthcare Ag	Substituierte Azachinazoline
DE102005027517A1 (de)	2005-06-15	2006-12-21	Bayer Healthcare Ag	Verfahren zur Herstellung von Dihydrochinazolinen
DE102011101446A1 (de)	2011-05-10	2012-11-15	Aicuris Gmbh & Co. Kg	Herstellung von "Dense Bodies" (DB)
DE102012101680A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat
DE102012101659A1 (de)	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Salze eines Dihydrochinazolinderivats
DE102012101673A1 (de)	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Salze eines Dihydrochinazolinderivats
MD4673C1 (ro) *	2013-06-19	2020-11-30	Aicuris Anti-Infective Cures Gmbh	Letermovir amorf şi forme preparative farmaceutice solide ale acestuia pentru administrare orală
WO2015088931A1 (fr) *	2013-12-12	2015-06-18	Merck Sharp & Dohme Corp.	Procédé de préparation de composés quinazoline substitués
WO2017091453A1 (fr) *	2015-11-24	2017-06-01	Merck Sharp & Dohme Corp.	Nouveaux procédés de production de composés de quinazoline substitués à l'aide de catalyseurs de liaison hydrogène
US10851112B2 (en)	2016-08-08	2020-12-01	Medshine Discovery Inc.	Anti-HCMV virus compound
KR102423393B1 (ko) *	2018-02-08	2022-07-21	파에노 테라퓨틱스 씨오., 엘티디.	3,4-디하이드로티에노[3,2-d]피리미딘 화합물의 결정형 및 이의 제조방법
EP3527209A1 (fr) *	2018-02-16	2019-08-21	UCB Biopharma SPRL	Dérivés pharmaceutiques de noyau hétérobicyclique 6,5
US11072610B2 (en)	2018-09-12	2021-07-27	Novartis Ag	Antiviral pyridopyrazinedione compounds
CN114667285B (zh)	2019-09-26	2025-08-08	诺华股份有限公司	抗病毒吡唑并吡啶酮化合物
AR121439A1 (es) *	2020-02-27	2022-06-08	Aic246 Gmbh & Co Kg	Un método para producir una forma cristalina de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il]acetato de sodio trihidrato
UY39098A (es) *	2020-02-27	2021-09-30	Aic246 Gmbh & Co Kg	2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5- (trifluorometil)fenil]-4h-quinazolin-4-il] acetato de sodio monohidrato, su preparación y uso
UY39097A (es) *	2020-02-27	2021-09-30	Aic246 Gmbh & Co Kg	Sal de potasio del ácido 2-[(4s)-8-fluoro-2-[4-(3- metoxifenil)piperazin-1-il]-3-[2-metoxi-5- (trifluorometil)fenil]-4h-quinazolin-4-il]acético
AR121438A1 (es)	2020-02-27	2022-06-08	Aic246 Gmbh & Co Kg	Composiciones farmacéuticas que comprenden acetato de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il] e iones de sodio
UY39099A (es)	2020-02-27	2021-08-31	Aic246 Gmbh & Co Kg	2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il] acetato de sodio y composiciones farmacéuticas del mismo
EP3906929A1 (fr)	2020-05-08	2021-11-10	AiCuris GmbH & Co. KG	Letermovir pour son utilisation dans la prévention et le traitement des infections à coronavirus
WO2022038457A1 (fr)	2020-08-17	2022-02-24	Lupin Limited	Procédé de précipitation de letermovir amorphe
CN115403528B (zh) *	2021-05-27	2025-01-07	南京正大天晴制药有限公司	无定形3,4-二氢喹唑啉衍生物的制备方法
CN114031560B (zh) *	2021-11-16	2022-10-04	山东诚创蓝海医药科技有限公司	一种来特莫韦钠盐的制备方法
UY40078A (es)	2021-12-21	2023-06-30	Aic246 Ag & Co Kg	Composiciones farmacéuticas que comprenden acetato de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin
CN118974026A (zh) *	2022-04-01	2024-11-15	上海迪赛诺化学制药有限公司	莱特莫韦中间体及其制备方法
CN115322157B (zh) *	2022-06-02	2023-12-05	浙江车头制药股份有限公司	来特莫韦中间体化合物及其制备方法和应用
CN117229223B (zh) *	2022-06-08	2026-06-05	博远医药(苏州)有限公司	一种杂环衍生物及其药物组合物、应用
AR134783A1 (es)	2023-12-21	2026-04-01	Aic246 Ag & Co Kg	Sales diastereoméricas de aminoalcohol y aminoéter de ácido 2-[(4r,s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-3,4-dihidroquinazolin-4-il]acético y su uso para separación enantiomérica
WO2026106929A1 (fr)	2024-11-14	2026-05-21	Assembly Biosciences, Inc.	Dihydroquinazolines utiles en tant qu'agents antiviraux contre le cytomégalovirus

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4320347A1 (de)	1993-06-19	1994-12-22	Boehringer Mannheim Gmbh	Quinazolin-Derivate und diese enthaltende Arzneimittel
US5854245A (en) *	1996-06-28	1998-12-29	Merck & Co., Inc.	Fibrinogen receptor antagonists
GB9718972D0 (en) *	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
DE19802437A1 (de)	1998-01-23	1999-07-29	Bayer Ag	Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
ATE245641T1 (de)	1998-02-17	2003-08-15	Tularik Inc	Antivirale pyrimidinderivate
PL351374A1 (en)	1999-04-19	2003-04-07	Shionogi & Co	Sulfonamide derivatives having oxadiazole rings
DE19930075A1 (de)	1999-06-30	2001-01-04	Bayer Ag	Neue Amino- und Amidosulfonamide als antivirale Mittel
US6730682B2 (en) *	2000-07-12	2004-05-04	Pharmacia & Upjohn Company	Heterocycle carboxamides as antiviral agents
WO2002010169A1 (fr) *	2000-07-31	2002-02-07	F. Hoffmann-La Roche Ag	Derives de la piperazine
EP1201765A3 (fr) *	2000-10-16	2003-08-27	Axxima Pharmaceuticals Aktiengesellschaft	Kinases cellulaires impliqués dans l'infection par cytomégalovirus et leur inhibition
BR0209054A (pt)	2001-04-19	2004-04-20	Bayer Ag	Arilsulfonamidas como agentes antivirais
DE10138578A1 (de)	2001-08-06	2003-02-27	Bayer Ag	Heterocyclylarylsulfonamide
DE10251914A1 (de) *	2002-11-08	2004-05-19	Bayer Ag	Substituierte Chinazoline
DE10319612A1 (de)	2003-05-02	2004-11-18	Bayer Healthcare Ag	Substituierte Dihydrochinazoline
DE10305785A1 (de) *	2003-02-12	2004-08-26	Bayer Healthcare Ag	Dihydrochinazoline
DE10320780A1 (de) *	2003-05-09	2005-01-20	Bayer Healthcare Ag	Heterocyclyl-substituierte Dihydrochinazoline
DE10352499A1 (de) *	2003-11-11	2005-06-09	Bayer Healthcare Ag	Substituierte Dihydrochinazoline II
KR100610731B1 (ko)	2004-02-24	2006-08-09	한국과학기술연구원	Ｔ-형 칼슘 채널 차단제로서 유용한 ３,４-디히드로퀴나졸린유도체 및 그의 제조 방법
DE102004022672A1 (de) *	2004-05-07	2005-11-24	Bayer Healthcare Ag	Substituierte Azachinazoline
BRPI0607306A2 (pt) *	2005-01-25	2009-08-25	Prolexys Pharmaceuticals Inc	derivados de quinoxalina como agentes anti-tumor
DE102005027517A1 (de)	2005-06-15	2006-12-21	Bayer Healthcare Ag	Verfahren zur Herstellung von Dihydrochinazolinen
WO2007009911A1 (fr) *	2005-07-21	2007-01-25	F. Hoffmann-La Roche Ag	Composes pyrido [2, 3-d] pyrimidine-2, 4-diamine utilises comme inhibiteurs de ptp1b
DE102006009928A1 (de)	2006-03-03	2007-09-06	Aicuris Gmbh & Co. Kg	Substituierte Arylsulfonamide
DE102012101659A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Salze eines Dihydrochinazolinderivats
DE102012101673A1 (de)	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Salze eines Dihydrochinazolinderivats
DE102012101680A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat
MD4673C1 (ro) *	2013-06-19	2020-11-30	Aicuris Anti-Infective Cures Gmbh	Letermovir amorf şi forme preparative farmaceutice solide ale acestuia pentru administrare orală

2003
- 2003-05-02 DE DE10319612A patent/DE10319612A1/de not_active Withdrawn
2004
- 2004-04-17 PL PL04728119T patent/PL1622880T6/pl unknown
- 2004-04-17 BR BRPI0410029A patent/BRPI0410029B8/pt not_active IP Right Cessation
- 2004-04-17 AU AU2004233978A patent/AU2004233978B2/en active Active
- 2004-04-17 RU RU2005137276/04A patent/RU2360912C2/ru active
- 2004-04-17 CA CA2524069A patent/CA2524069C/fr not_active Expired - Lifetime
- 2004-04-17 CN CNB2004800119284A patent/CN100393706C/zh not_active Expired - Lifetime
- 2004-04-17 AT AT04728119T patent/ATE355280T1/de active
- 2004-04-17 MX MXPA05011707A patent/MXPA05011707A/es active IP Right Grant
- 2004-04-17 SI SI200430301T patent/SI1622880T1/sl unknown
- 2004-04-17 PT PT04728119T patent/PT1622880E/pt unknown
- 2004-04-17 DK DK04728119.1T patent/DK1622880T6/da active
- 2004-04-17 NZ NZ543317A patent/NZ543317A/en not_active IP Right Cessation
- 2004-04-17 ES ES04728119.1T patent/ES2284007T7/es active Active
- 2004-04-17 WO PCT/EP2004/004103 patent/WO2004096778A1/fr not_active Ceased
- 2004-04-17 KR KR1020057020720A patent/KR100927063B1/ko not_active Expired - Lifetime
- 2004-04-17 EP EP04728119.1A patent/EP1622880B3/fr not_active Expired - Lifetime
- 2004-04-17 DE DE502004003052T patent/DE502004003052D1/de not_active Expired - Lifetime
- 2004-04-17 UA UAA200511418A patent/UA82519C2/uk unknown
- 2004-04-17 JP JP2006505178A patent/JP4733631B2/ja not_active Expired - Lifetime
- 2004-04-23 AR ARP040101391A patent/AR044078A1/es active IP Right Grant
- 2004-04-26 US US10/832,109 patent/US7196086B2/en not_active Ceased
- 2004-04-28 UY UY28294A patent/UY28294A1/es not_active IP Right Cessation
- 2004-04-29 MY MYPI20041603A patent/MY144616A/en unknown
- 2004-04-29 HN HN2004000146A patent/HN2004000146A/es unknown
- 2004-04-30 CL CL200400930A patent/CL2004000930A1/es unknown
- 2004-04-30 PE PE2004000432A patent/PE20050145A1/es active IP Right Grant
- 2004-04-30 TW TW093112100A patent/TWI335912B/zh active
2005
- 2005-10-20 IL IL171513A patent/IL171513A/en active IP Right Grant
- 2005-10-27 ZA ZA2005/08710A patent/ZA200508710B/en unknown
- 2005-10-29 EG EGNA2005000688 patent/EG25273A/xx active
- 2005-11-01 EC EC2005006138A patent/ECSP056138A/es unknown
- 2005-11-02 CO CO05111848A patent/CO5700764A2/es active IP Right Grant
- 2005-11-08 MA MA28581A patent/MA27794A1/fr unknown
- 2005-11-30 NO NO20055649A patent/NO333265B3/no active Protection Beyond IP Right Term
2007
- 2007-03-26 US US11/728,896 patent/US8513255B2/en active Active
- 2007-05-25 CY CY20071100709T patent/CY1106476T1/el unknown
2015
- 2015-04-09 US US14/682,512 patent/USRE46791E1/en active Active
2018
- 2018-04-17 NL NL300933C patent/NL300933I2/nl unknown
- 2018-04-21 HU HUS1800018C patent/HUS1800018I1/hu unknown
- 2018-06-15 HU HUS1800028C patent/HUS1800028I1/hu unknown
- 2018-06-29 CY CY2018019C patent/CY2018019I2/el unknown
- 2018-07-04 NO NO2018022C patent/NO2018022I1/no unknown
- 2018-07-06 FR FR18C1029C patent/FR18C1029I2/fr active Active
2020
- 2020-07-21 US US16/934,363 patent/USRE49698E1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
BRPI0410029A (pt)	2006-04-25
AU2004233978A1 (en)	2004-11-11
BRPI0410029B8 (pt)	2021-06-15
RU2005137276A (ru)	2006-07-27
MXPA05011707A (es)	2006-02-13
KR20060009883A (ko)	2006-02-01
IL171513A (en)	2011-11-30
KR100927063B1 (ko)	2009-11-13
EP1622880B1 (fr)	2007-02-28
PL1622880T3 (pl)	2007-08-31
CY2018019I1 (el)	2018-12-12
RU2360912C2 (ru)	2009-07-10
ECSP056138A (es)	2006-04-19
AU2004233978B2 (en)	2010-02-11
HK1092463A1 (zh)	2007-02-09
PT1622880E (pt)	2007-06-04
CL2004000930A1 (es)	2005-03-18
CA2524069A1 (fr)	2004-11-11
USRE46791E1 (en)	2018-04-17
DE10319612A1 (de)	2004-11-18
NZ543317A (en)	2008-05-30
DK1622880T3 (da)	2007-06-25
EP1622880B3 (fr)	2018-05-23
EG25273A (en)	2011-12-04
US7196086B2 (en)	2007-03-27
NO20055649D0 (no)	2005-11-30
PE20050145A1 (es)	2005-05-22
CY2018019I2 (el)	2018-12-12
ES2284007T7 (es)	2018-06-20
CA2524069C (fr)	2011-11-08
EP1622880A1 (fr)	2006-02-08
ATE355280T1 (de)	2006-03-15
JP2006525249A (ja)	2006-11-09
US20070191387A1 (en)	2007-08-16
US8513255B2 (en)	2013-08-20
MY144616A (en)	2011-10-14
CY1106476T1 (el)	2012-01-25
NO2018022I1 (no)	2018-07-04
NL300933I2 (nl)	2018-04-26
DE502004003052D1 (de)	2007-04-12
SI1622880T1 (sl)	2007-08-31
NO333265B1 (no)	2013-04-22
UA82519C2 (uk)	2008-04-25
TWI335912B (en)	2011-01-11
NO20055649L (no)	2006-01-31
US20050065160A1 (en)	2005-03-24
HUS1800028I1 (hu)	2018-07-30
FR18C1029I1 (fr)	2018-08-17
TW200510343A (en)	2005-03-16
ES2284007T3 (es)	2007-11-01
NO333265B3 (no)	2019-06-03
BRPI0410029B1 (pt)	2019-12-31
JP4733631B2 (ja)	2011-07-27
PL1622880T6 (pl)	2018-08-31
CN100393706C (zh)	2008-06-11
CO5700764A2 (es)	2006-11-30
CN1784390A (zh)	2006-06-07
UY28294A1 (es)	2004-11-30
HN2004000146A (es)	2008-06-24
WO2004096778A1 (fr)	2004-11-11
DK1622880T6 (da)	2018-06-18
USRE49698E1 (en)	2023-10-17
MA27794A1 (fr)	2006-03-01
ZA200508710B (en)	2006-12-27
AR044078A1 (es)	2005-08-24
HUS1800018I1 (hu)	2018-05-28

Publication	Publication Date	Title
CY2018019I1 (el)	2018-12-12	Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες
DE602005015466D1 (de)	2009-08-27	Antivirale 4'-azidonucleoside
ATE363383T1 (de)	2007-06-15	Schlingenware
DE602004018130D1 (de)	2009-01-15	Kaffeeaufbrühvorrichtung
DK1622630T3 (da)	2012-12-17	P009368epdk1
AT502792A5 (de)	2007-05-15	Düsenanpressvorrichtung
EP1596079A4 (fr)	2006-10-04	Pallier a glissement
DE10355350A8 (de)	2006-11-09	Elektromodul
ATA662003A (de)	2005-11-15	Trink-mundstück
ATE446959T1 (de)	2009-11-15	Chromenonindole
SE0402012L (sv)	2005-02-23	Mitgehflurförderzeug
DE602004014793D1 (de)	2008-08-14	Acrylsolzusammensetzung
DE10394329D2 (de)	2006-10-05	Mäanderstent
ATE504278T1 (de)	2011-04-15	Hosenförmiger artikel mit verbesserter passform
ATE406350T1 (de)	2008-09-15	Prolinylarylacetamide
DE10329218B4 (de)	2007-05-16	Hotflue
DE112004000759D2 (de)	2006-05-18	Banknote mit Schaltkreis
AT500001B8 (de)	2007-02-15	Münzscheideeinrichtung
ATA1802003A (de)	2005-12-15	Verbundhonring
AT500231B8 (de)	2007-02-15	Übergangsstück
DE50307365D1 (de)	2007-07-12	Etui
FR2855873B1 (fr)	2007-06-22	Fusil a repetition
DE10316511B4 (de)	2005-10-20	Teigportionierer
AT6592U3 (de)	2004-05-25	Frontgrubber
ATA80232004A (de)	2005-09-15	Kurbelgehäuse